Cell Death Pathways in Photodynamic Therapy of Cancer
By Pawel Mróz, A. Yaroslavsky, Gitika B. Kharkwal, Michael R Hamblin. Cancers, 2011
631 citations recorded by the source corpus.
Photodynamic therapy (PDT) is an emerging cancer therapy that uses the combination of non-toxic dyes or photosensitizers (PS) and harmless visible light to produce reactive oxygen species and destroy tumors. The PS can be localized in various organelles such as mitochondria, lysosomes, endoplasmic reticulum, Golgi apparatus and plasma membranes and this sub-cellular location governs much of the signaling that occurs after PDT. There is an acute stress response that leads to changes in calcium and lipid metabolism and causes the production of cytokines and stress response mediators. Enzymes (particularly protein kinases) are activated and transcription factors are expressed. Many of the cellular responses center on mitochondria and frequently lead to induction of apoptosis by the mitochondrial pathway involving caspase activation and release of cytochrome c. Certain specific proteins (such as Bcl-2) are damaged by PDT-induced oxidation thereby increasing apoptosis, and a build-up of oxidized proteins leads to an ER-stress response that may be increased by proteasome inhibition. Autophagy plays a role in either inhibiting or enhancing cell death after PDT.
Subfields: Biomedical Engineering, Molecular Biology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/4b9e0f9b39f8dd90226382ff142b921d739c24ab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- H. S. de Bruijn
- Demian van Straten
- D. Robinson
- Vida Mashayekhi
- S. Oliveira
Citations in the corpus
- Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions (2017, background): “Nevertheless, some general themes can be observed [28].”